Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Product 0405 in pediatric mild to moderate atopic dermatitis
NCT02176538Phase 3Withdrawn
- Sponsor
- Fougera Pharmaceuticals Inc.
- Start
- Jun 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Product 0405 in atopic dermatitis (AD), sponsored by Fougera Pharmaceuticals Inc.. Planned start Jun 2012; status: withdrawn.
02
Drugs
Product 0405
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02176538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176538.